Dr. Himanshu Bansal

OVERVIEW

Raised in small town of  Rudrapur Uttrakhand India, Dr.Bansal completed his medical school residency and post graduation in orthopaedic surgery from King George Medical College Lucknow.  During his post graduation itself, he actively pursued research on spinal cord injury and developed classification based on Xrays and MRI .

He further enriched himself at Osaka city university Hospital, Osaka, Japan/Aarhus University Hospital at Denmark/Guy’s Hospital of Kings College, London/Wurzburg university Hospital, Germany

Osaka city university Hospital, Osaka, Japan

Because of his interest for striving excellence in management of CNS disorders and spinal cord injury, He undertook various visits and research associations at Miami Project to Cure Paralysis (Miami University) USA.//Reeve-Irvine Research Center, California USA.// Queen Elizabeth Spinal Trauma Centre, Glasgow, Scotland.//Neuroscience Center-Rutgers University USA//Egaz Monis hospital, lisbon , Portugal //European spinal cord research institute, Brescia Italy//The Institute of experimental medicine Prague//Beatson Institute, university of  Glasgow//Saint Gerkatuen Hospital, Berlin Germany

He is invited as Guest Speaker at various conferences and symposium in India and all across world . Chief collaborator in the Graduate Institute Geneva project titled “The Emergence Of Stem Cell Biotechnologies In India”( European Research Council)

Actively involved in clinical research with autologous bone marrow,fat derived cells in orthopaedic and neurodegenerative diseases. Pioneered several new protocols for treatment of CNS injuries (Brain Injury ,Spinal cord injury ), Cerebral palsy, Autism, Optic atrophy, Multiple sclerosis, ALS and other neurodegenerative disorders. Future plan is clinical research involving adult pluripotent stem cells  ( VSEL and MUSE cells)

He is amongst the first few Indian clinicians to start treating Critical limb ischemia, AVN, Difficult Non-union, Non healing woundswith autologus stem cells.

Recently Initiated  overenthusiastic, challenging  multimodality approach to reverse brain death (first time in world )with early encouraging results.  Conducting  studies with a) adiposed derived cells in Osteoarthritis of knee b) scar reduction, olfactory tissue transplantation in chronic spinal injury , intralesional bone marrow derived cells implantation in spinal cord injury.

See also  Dr. Miguel Garber

Developed Interlocking Nailing System for fractures of Radius and Ulna (Patent Granted), locked nail for fractures of lower end radius and has corresponding publications to his credit.

Using autlogous stem cells He has successfully reversed methanol induced optic( case reported for the first time in world)  traumatic brain injury. (case reported for the first time from India)

Finished and published Cardiac study with Bioheart USA ; Osteoarthritis Knee study with advance health insititute  Puerto Rico USA,  mineral supplemtation in knee OA

Developed a new protocol  for Spinal cord injury  with duroplasty, omental transposition at ( ISCI Iceland supported first ever study in World)

Co-Investigated non commercial study with  neurology group Connecticut USA  (2014)with autologous bone marrow &Adipose derived stem cells in ALS patients  

Amity Institute of Neuropsychology & Neurosciences, Amity University, Noida, Uttar Pradesh, India.
2Department of Health and Family Welfare, Civil Hospital Narwana, Haryana, India.
India
Contact for One on One clinical training

EDUCATION

M.B.B.S., M.S. (Surgery)

(India)

Micro Surgery

(Osaka, Japan)

Hip & Knee Surgery (London, UK)

Surgery

Spine ,hip& knee

(Aarhus, Denmark)

Traumatology

(Wuzburg, Germany)

Spinal Cord Injury (USA | Portugal | Italy )

Spinal Cord Injury (USA | Portugal | Italy )

Stem cell Research (UK | Czech | Germany )

Stem cell Research (UK | Czech | Germany )

Stem Cell Research

Application of autologous bone marrow,adipose &dental pulp derived stem
cells in neurology & Orthopaedic diseases
Spinal cord injury, Cerebral palsy, Autism, Optic atrophy, Parkinsonism,
Multiple sclerosis, Traumatic brain injury stroke…
Critical limb ischemia, AVN, Non-union, Osteoarthritis…
Developing human VSELS culture facilities.
Multimodality approach in reviving Brain dead subjects
Comprehensive treatment approach in chronic spinal injured patients.

2016

Initiating first time in world multimodality approach to reverse
brain death in 20 subjects using autologous stem cells,electric ,laser
and peptide stimulation

2015

Phase II/III study with autologous adipose tissue derived
mesenchymal cells in Osteoarthritis of knee.
Phase II clinical trial with allogenic umbilical cord tissue derived
mesenchymal cells in Osteoarthritis of knee.
Finishedphase I/II study IntralesionalVs scaffold filled administration of
stem cells in chronic spinal cord Injury.
Completed Phase I/II study with autologous adipose tissue SVF in10
patients of Osteoarthritis knee.

2014

Co Investigator in IRB approved study with autologous bone marrow&
Adipose derived stem cells in ALS patients at USA.

Stem cell Research

2013] Successfully treated vegetative patients following traumatic brain injury
by noninvasive implantation of autologous MSCs.
[2011] Successfully reversed methanol induced optic atrophy in patients by
bone marrow derived cocktail of stem cells
[Case series reported for the first time in world]
[2010] Operated and conducted study “|Duroplasty with omental transpositionin
acute spinal cord injury|
[First time in world collaboration with ISCI Iceland]
[2009] Operated and conducted phase 1/11 trial with scar reduction &
olfactory tissue transplantation in chronic spinal cord injury.

See also  Dr. Rashad Haddad

PUBMED

Bansal H, Leon J, Pont JL, Wilson DA, Bansal A, Agarwal D, Preoteasa I. Author Correction: Platelet‑rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy.

Sci Rep. 2021 Sep 14;11(1):18612. doi: 10.1038/s41598-021-98365-2. Erratum for: Sci Rep. 2021 Feb 17;11(1):3971. PMID: 34521970; PMCID: PMC8440621.

Bansal H, Kumar V, Mehta R. Diagnostic comparison of biochemical profile in patients with Covid-19, dengue and Acute Febrile illness: Implications for patient management.

Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100844. doi: 10.1016/j.cegh.2021.100844. Epub 2021 Aug 3. PMID: 34368504; PMCID: PMC8330144.Clin Epidemiol Glob Health. 2021 Oct-Dec;12:100844. doi: 10.1016/j.cegh.2021.100844. Epub 2021 Aug 3. PMID: 34368504; PMCID: PMC8330144.

Bansal H, Ravina M, Chandrakar PK, Lukose TT, Krishna S. Orbital Plasmablastic Lymphoma: A Rare Variant of Diffuse Large B-Cell Lymphoma Staged and Followed Up by 18F-FDG PET/CT.

Clin Nucl Med. 2021 Jul 14. doi: 10.1097/RLU.0000000000003805. Epub ahead of print. PMID: 34269735.

PUBMED

Bansal H, Gupta N, Roy S. Theoretical analysis of optogenetic spiking with ChRmine, bReaChES and CsChrimson-expressing neurons for retinal prostheses.

J Neural Eng. 2021 Jul 26;18(4). doi: 10.1088/1741-2552/ac1175. PMID: 34229315.

Bansal H, Comella K, Leon J, Verma P, Agrawal D, Koka P, Ichim T. Retraction Note to: Intra-articular injection in the knee of adipose derived stromal cells (stromal vascular fraction) and platelet rich plasma for osteoarthritis.

J Transl Med. 2021 Apr 26;19(1):168. doi: 10.1186/s12967-021-02852-z. PMID: 33902642; PMCID: PMC8074508.

Bansal H, Ravina M, Nanda S, Lukose TT, Krishna S. Diffuse White Adipose Tissue 18F-FDG Uptake-An Unusual Finding on 18F-FDG PET/CT.

Clin Nucl Med. 2021 Oct 1;46(10):e513-e514. doi: 10.1097/RLU.0000000000003652. PMID: 33867453.

Choose language »